← All trials
NCT04840823
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 26, 2021
- Primary completion
- Dec 31, 2021
- Completion date
- Dec 31, 2021
- First posted
- Apr 12, 2021
- Last posted
- May 19, 2021
- Enrollment
- 36
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- McGill UniversityLead sponsor
- ApotexCollaborator
- McGill UniversityOverall official - principal investigator
- McGill UniversityReponsible party - principal investigator
- Weizmann Institute of ScienceCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.